An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection

Clinical trial NCT02278419 · COMPLETED

Trial details

NCT number

NCT02278419

Sponsor

Janssen-Cilag International NV

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-12-01

Primary completion

2015-10-01

Enrollment

63

View on ClinicalTrials.gov